Endoskopie 2011; 20(1): 34-38

Photoselective vaporization of prostate in benign prostatic hyperplazia therapy

MUDr.Miroslav Záleský, Ph.D., doc.MUDr.Roman Zachoval, Ph.D.
Urologické oddělení Fakultní Thomayerovy nemocnice, Praha

Aim: Aim of this publication is to summarize information about photoselective vaporization of prostate (PVP).

Methods: All publications connected with mesh terms „photoselective vaporization prostate“ were searched in Medline database. This

review is based on this publication and on our experiences with PVP.

Results: PVP improves significantly symptoms of benign prostatic hyperplasia. Complication rate of PVP is lower than complication rate

of transurethral resection of prostate (TURP). Time of catheterization and hospitalization after PVP is shorter than after TURP. Long term

results of PVP are not available yet.

Conclusions: Short and mid-term results of PVP and TURP are comparable, complication rate of PVP is lower.

Keywords: photoselective vaporization of prostate, laser, benign prostatic hyperplazia

Published: May 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Záleský M, Zachoval R. Photoselective vaporization of prostate in benign prostatic hyperplazia therapy. Endoskopie. 2011;20(1):34-38.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Shingleton WB, Terrell F, Renfroe DL, et al. A randomized prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 1999; 54: 1017-1021. Go to original source... Go to PubMed...
    2. Malek RS, Barrett DM, Kuntzman RS. High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 1998; 51: 254-256. Go to original source... Go to PubMed...
    3. Hai MA, Malek RS. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 2003; 17: 93-96. Go to original source... Go to PubMed...
    4. Malek RS, Kang HW, Coad JE, et al. Greenlight photoselective 120-watt 532-nm lithium triborate laser vaporization prostatectomy in living canines. J Endourol 2009; 23: 837-845. Go to original source... Go to PubMed...
    5. Alivizatos G, Skolarikos A, Chalikopoulos D, et al. Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas > 80 ml: 12-mo results of a randomized prospective study. Eur Urol 2008; 54: 427-437. Go to original source... Go to PubMed...
    6. Sandhu JS, Ng C, Vanderbrink BA, et al. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004; 64: 1155-1159. Go to original source... Go to PubMed...
    7. Rajbabu K, Chandrasekara SK, Barber NJ, et al. Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of > 100 mL. BJU Int 2007; 100: 593-598; discussion 8. Go to original source... Go to PubMed...
    8. Woo HH. Photoselective vaporization of the prostate using the 120-W lithium triborate laser in enlarged prostates (120 cc). BJU Int 2011; Article first published online: 24 NOV 2010. Go to original source...
    9. Schwartz J, Renard J, Wolf JP, et al. High-power potassium-titanyl-phosphate laser fibres for endovaporization of benign prostatic hyperplasia: how much do they deteriorate during the procedure? BJU Int 2011; Article first published online: 29 OCT 2010. Go to original source...
    10. Pedersen JM, Romundstad PR, Mjones JG, et al. 2-year followup pressure flow studies of prostate photoselective vaporization using local anesthesia with sedation. J Urol 2009; 181: 1794-1799. Go to original source... Go to PubMed...
    11. Spaliviero M, Araki M, Page JB, et al. Catheter-free 120 W lithium triborate (LBO) laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). Lasers Surg Med 2008; 40: 529-534. Go to original source... Go to PubMed...
    12. Te AE, Malloy TR, Stein BS, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 2004; 172: 1404-1408. Go to original source... Go to PubMed...
    13. Te AE, Malloy TR, Stein BS, et al. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 2006; 97: 1229-1233. Go to original source... Go to PubMed...
    14. Spaliviero M, Araki M, Culkin DJ, et al. Incidence, management, and prevention of perioperative complications of GreenLight HPS laser photoselective vaporization prostatectomy: experience in the first 70 patients. J Endourol 2009; 23: 495-502. Go to original source... Go to PubMed...
    15. Spaliviero M, Araki M, Wong C. Short-term outcomes of Greenlight HPS laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). J Endourol 2008; 22: 2341-2347. Go to original source... Go to PubMed...
    16. Bachmann A, Schurch L, Ruszat R, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005; 48: 965-71; discussion 72. Go to original source... Go to PubMed...
    17. Bouchier-Hayes DM, Anderson P, Van Appledorn S, et al. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 2006; 20: 580-585. Go to original source... Go to PubMed...
    18. Tasci AI, Tugcu V, Sahin S, et al. Rapid communication: photoselective vaporization of the prostate versus transurethral resection of the prostate for the large prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol 2008; 22: 347-353. Go to original source... Go to PubMed...
    19. Horasanli K, Silay MS, Altay B, et al. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial. Urology 2008; 71: 247-251. Go to original source... Go to PubMed...
    20. Tugcu V, Tasci AI, Sahin S, et al. Comparison of photoselective vaporization of the prostate and transurethral resection of the prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol 2008; 22: 1519-1525. Go to original source... Go to PubMed...
    21. Ruszat R, Wyler SF, Seitz M, et al. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study. BJU Int 2008; 102: 1432-1438; discussion 8-9. Go to original source... Go to PubMed...
    22. Skolarikos A, Papachristou C, Athanasiadis G, et al. Eighteen-month results of a randomized prospective study comparing transurethral photoselective vaporization with transvesical open enucleation for prostatic adenomas greater than 80 cc. J Endourol 2008; 22: 2333-2340. Go to original source... Go to PubMed...
    23. Nomura H, Seki N, Yamaguchi A, et al. Comparison of photoselective vaporization and standard transurethral resection of the prostate on urodynamics in patients with benign prostatic hyperplasia. Int J Urol 2009; 16: 657-662. Go to original source... Go to PubMed...
    24. Bouchier-Hayes DM, Van Appledorn S, Bugeja P, et al. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int 2010; 105: 964-969. Go to original source... Go to PubMed...
    25. Al-Ansari A, Younes N, Sampige VP, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol.
    26. Goh AC, Gonzalez RR. Photoselective laser vaporization prostatectomy versus transurethral prostate resection: a cost analysis. J Urol 183: 1469-1473. Go to original source... Go to PubMed...
    27. Reich O, Bachmann A, Siebels M, et al. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005; 173: 158-160. Go to original source... Go to PubMed...
    28. Sandhu JS, Ng CK, Gonzalez RR, et al. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005; 19: 1196-1198. Go to original source... Go to PubMed...
    29. Ruszat R, Wyler S, Forster T, et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 2007; 51: 1031-1038; discussion 8-41. Go to original source... Go to PubMed...
    30. Naspro R, Bachmann A, Gilling P, et al. A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate. Eur Urol 2009; 55: 1345-1357. Go to original source... Go to PubMed...
    31. Kabilka T, Veselý R. Fotoselektivní vaporizace prostaty Green Light laserem - naše první zkušenosti. Urolog. pro Praxi 2009; 10: 244-245.

    Return to the content


    Endoscopy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.